Search Results
Found 578 results
510(k) Data Aggregation
(158 days)
Syringe (SC250AN); StaClear Syringe (SC250LS); StaClear Syringe (SC250LL)
Regulation Number: 21 CFR 880.5860
Piston Syringe |
| Classification Name: | Ophthalmic Syringe |
| Regulation Number: | 21 CFR 880.5860
SC250AN, SC250LS, SC250LL | SC250AN, SC250LS, SC250LL | Identical |
| Regulation Number | 21 CFR 880.5860
| 21 CFR 880.5860 | Identical |
| Product Code(s) | QLY, FMF, FMI | QLY, FMF, FMI | Identical |
The StaClear Syringe is intended to inject fluids into, or withdraw fluids from, the body. The StaClear Syringe is indicated for intravitreal use.
The StaClear Syringe is a sterile, single-use, manually operated piston syringe intended for general-purpose aspiration and injection of fluids by trained healthcare professionals. It is suitable for ophthalmic applications, including intravitreal injections. The syringe functions using standard positive-displacement mechanics, in which movement of the plunger creates pressure differentials to aspirate or expel fluid.
The StaClear Syringe is offered in the following configurations:
- SC250AN: Consisting of a 0.25 mL graduated barrel, plunger, plunger stopper, needle, needle shield, and optional plunger cap.
- SC250LS: Consisting of a 0.25 mL graduated barrel with an ISO 80369-7-compliant luer-slip connector, plunger, and plunger stopper.
- SC250LL: Consisting of a 0.25 mL graduated barrel with an ISO 80369-7-compliant luer-lock connector, plunger, and plunger stopper.
All three configurations were previously cleared under K243936. This submission introduces no changes to the device's design, dimensions, materials, or intended use. The only modification is the addition of a rigid PETG tray sealed with a Tyvek lid as an alternative sterile barrier packaging configuration.
The device's intended use, design, materials, sterilization method (EO), and labeled shelf life (5 years) remain unchanged.
N/A
Ask a specific question about this device
(228 days)
Jordan, Utah 84095
Re: K250853
Trade/Device Name: Merit Syringe
Regulation Number: 21 CFR 880.5860
Jordan, Utah 84095
Re: K250853
Trade/Device Name: Merit Syringe
Regulation Number: 21 CFR 880.5860
Classification Name: | Syringe, Piston |
| Regulatory Class: | 2 |
| Product Code: | FMF |
| 21 CFR §: | 880.5860
Classification Name: | Syringe, Piston |
| Regulatory Class: | 2 |
| Product Code: | FMF |
| 21 CFR §: | 880.5860
consensus standards have been established for Piston Syringes under FDA Product Code FMF and 21 CFR 880.5860
The Merit Syringe is used to inject fluids into, and withdraw fluids from, the body.
The Merit Syringe a standard three-piece piston syringe intended for general purpose injection and aspiration by a qualified clinician. The syringe is constructed of a calibrated, hollow, clear polycarbonate barrel into which is inserted a closely fitted movable ABS plunger with black silicone rubber piston seal (tip). The barrel is marked with standard graduations per ISO 7886-1 requirements and contains an ISO 80369-7 compliant fixed male luer, small-bore connector. The subject device is single use and is available in either an ethylene oxide (EO) or gamma-sterile configuration.
N/A
Ask a specific question about this device
(236 days)
15213
Re: K250510
Trade/Device Name: Sure-Fine Insulin Syringes
Regulation Number: 21 CFR 880.5860
Syringe
3) Classification name: Syringe, Piston
4) Product code: FMF
5) Regulation number: 880.5860
Sure-Fine Insulin Syringes are hypodermic insulin syringes for subcutaneous injection of U100 insulin.
Sure-Fine Insulin syringes are designed for the subcutaneous injection of a desired dose of insulin. The syringe has a graduated barrel(U-100), a plunger rod, needle cap, protective end cap and needle permanently affixed to the tip of the syringe with epoxy.
The syringes are available in the following size and cap color.
| Category | Insulin Syringe | Needle gauge | Needle length | Cap Color |
|---|---|---|---|---|
| Needle Cap | ||||
| U-100 | 1 cc | 27 Gauge | 1/2″ | Orange |
| 1 cc | 27 Gauge | 5/16″ | ||
| 1/2cc and 1 cc | 28 Gauge | 1/2″ | ||
| 1/2cc and 1 cc | 28 Gauge | 5/16″ | ||
| 3/10cc, 1/2cc and 1 cc | 29 Gauge | 1/2″ | ||
| 3/10cc, 1/2cc and 1 cc | 29 Gauge | 5/16″ | ||
| 3/10cc, 1/2cc and 1 cc | 30 Gauge | 1/2″ | ||
| 3/10cc, 1/2cc and 1 cc | 30 Gauge | 5/16″ | ||
| 3/10cc and 1/2cc | 30 Gauge | 1/4″ | ||
| 3/10cc, 1/2cc and 1 cc | 31 Gauge | 5/16″ | ||
| 3/10cc and 1/2cc | 31 Gauge | 1/4″ |
N/A
Ask a specific question about this device
(252 days)
Switzerland
Re: K243901
Trade/Device Name: SmartPilot YpsoMate NS-A2.25
Regulation Number: 21 CFR 880.5860
Common or Usual Name: Injection Data Capture Device
Classification Name: Piston Syringe (21 CFR 880.5860
is that the SmartPilot does not capture dosing information. |
| ProCode / Reg # | QOG / 21 CFR 880.5860
| QOG / 21 CFR 880.5860 | Same |
| Class / Reg Pathway | Class II / 510(k) | Class II / 510(k) |
The SmartPilot YpsoMate NS-A2.25 is indicated for use with the compatible disposable autoinjector to capture and record injection information that provides feedback to the user.
The SmartPilot YpsoMate NS-A2.25 is an optional, battery operated, reusable device designed to be used together with a compatible autoinjector (a single use, needle based, pre-filled injection device for delivery of a drug or biologic into subcutaneous tissue). Figure 1 shows the SmartPilot YpsoMate NS-A2.25 with the paired autoinjector. The SmartPilot YpsoMate NS-A2.25 records device data, injection data and injection process status. The SmartPilot YpsoMate NS-A2.25 also provides guidance feedback to the user during the injection.
Note that the SmartPilot YpsoMate NS-A2.25 does not interfere with autoinjector function.
The provided 510(k) clearance letter details the substantial equivalence of the SmartPilot YpsoMate NS-A2.25 device to its predicate. While it lists various performance tests and standards met, it does not contain specific acceptance criteria values or detailed study results for metrics like sensitivity, specificity, or improvement in human reader performance. This document primarily focuses on demonstrating that the new device does not raise new questions of safety and effectiveness compared to the predicate, due to similar technological characteristics and adherence to relevant safety standards.
Therefore, many of the requested details about acceptance criteria, study design (sample size, data provenance, expert adjudication, MRMC studies), and ground truth establishment (especially for AI-driven performance) cannot be extracted directly from this regulatory document. The information primarily pertains to hardware, software, and usability testing.
However, based on the provided text, here's what can be inferred or stated about the device's acceptance criteria and proven performance:
Device: SmartPilot YpsoMate NS-A2.25
Indication for Use: The SmartPilot YpsoMate NS-A2.25 is indicated for use with the compatible disposable autoinjector to capture and record injection information that provides feedback to the user. Specifically compatible with Novartis/Sandoz Secukinumab (Cosentyx).
1. Table of Acceptance Criteria and Reported Device Performance
The document does not provide a table with quantitative acceptance criteria and reported performance values for metrics typically associated with AI/software performance (e.g., sensitivity, specificity, accuracy of data capture in a clinical context). Instead, it focuses on meeting established engineering, safety, and quality standards.
Here's a summary of the types of performance criteria implied by the successful completion of the listed tests:
| Acceptance Criterion (Implied) | Reported Device Performance (Achieved) | Supporting Test / Standard |
|---|---|---|
| Biocompatibility | Meets requirements for intact skin contact. | ISO 10993-1, -5, -10, -23 |
| Compatibility with Autoinjector | No negative impact on Essential Performance Requirements (EPRs) of compatible YpsoMate 2.25ml autoinjector. | ISO 11608-1:2022, ISO 11608-5:2022 (Influence Testing) |
| Basic Safety | Complies with general safety standards. | IEC 60601-1, Ed.3.2 2020-08 |
| Electromagnetic Compatibility (EMC) | Complies with EMC standards. | IEC 60601-1-2:2014 incl. AMD 1:2021 |
| Battery Safety | Complies with battery safety standards. | IEC 62133-2:2017 + A1:2021 |
| Wireless Communication (FCC) | Complies with FCC regulations for wireless devices. | FCC 47 CFR Part 15B, Part 15.225, Part 15.247 |
| Wireless Coexistence | Complies with standards for wireless coexistence. | IEEE ANSI USEMCSC C63.27-2021; AIM 7351731:2021 |
| Software Verification & Validation | Documentation level "enhanced," meets requirements for safety, cybersecurity, and interoperability. Software classified as B per ANSI AAMI ISO 62304:2006/A1:2016. | FDA Guidance on Software Functions, ANSI AAMI ISO 62304, Cybersecurity Testing, Interoperability testing |
| Electrical Hardware Functionality | BLE, NFC, inductance measurement, electromechanical switches, motion detection, temperature measurement all functional. | Electrical Hardware Requirements Testing |
| Indicator & Feedback Systems | Visual (LEDs with specified wavelength/intensity) and acoustic (adjustable sound volume) feedback systems are functional. | Electrical Hardware Requirements Testing |
| Durability & Lifetime | Meets specifications for switching cycles, 3-year storage, 2-year or 120-use operational lifespan, and operational tolerances. | Electrical Hardware Requirements Testing, Lifetime and Shelf Life Testing |
| Mechanical Integrity | Withstands use force, axial/twisting loads on inserted autoinjector, and maintains locking flag visibility. | Mechanical Testing |
| Shelf Life | Achieves a 3-year shelf life. | Shelf Life Testing |
| Human Factors/Usability | Complies with human factors engineering standards; formative and summative usability evaluations completed. | IEC 60601-1-6:2010/AMD2:2020, ANSI AAMI IEC 62366-1:2015 + AMD1 2020 |
| Transportation Safety | Maintains integrity after transportation simulation. | ASTM D4169-22 |
| Dose Accuracy (Influence) | Meets ISO 11608-1 requirements when evaluated with compatible YpsoMate AutoInjectors. This is related to the autoinjector's performance when used with the SmartPilot, not the SmartPilot's accuracy in measuring dose itself, as it states the SmartPilot "does not capture dosing information." | Influence Testing based on ISO 11608-1:2022 |
Note: The device's primary function is to "capture and record injection information that provides feedback to the user," and it "does not capture dosing information" or "electronically controlled dosing." Therefore, criteria related to dosing volume accuracy or AI interpretation of medical images/signals for diagnosis are not applicable to this device. The focus is on the accurate capture of event data (injection start/end, result) and providing timely feedback, as well as general device safety and functionality.
2. Sample Size Used for the Test Set and Data Provenance
The document describes various types of tests (e.g., Biocompatibility, EMC, Software V&V, Mechanical, Lifetime, Human Factors), but does not specify the sample sizes used for each test dataset.
Data Provenance: The document does not explicitly state the country of origin for the data or whether the studies were retrospective or prospective. Given that Ypsomed AG is based in Switzerland and the testing references international and US standards, the testing likely involved a mix of internal validation, third-party lab testing, and possibly user studies in relevant regions. All tests described are part of preclinical (non-clinical) performance validation, making them inherently prospective for the purpose of demonstrating device function and safety prior to marketing.
3. Number of Experts and Qualifications for Ground Truth
The document does not mention the use of experts in the context of establishing ground truth for the device's functional performance, as it is not an AI-driven diagnostic or interpretative device that relies on human expert consensus for its output. Its performance is evaluated against engineering specifications and physical/software functional requirements. The "Human Factors" testing would involve users, but not necessarily "experts" adjudicating correctness in the sense of accuracy for a diagnostic task.
4. Adjudication Method for the Test Set
Not applicable. The device's performance is determined by meeting pre-defined engineering and regulatory standards and testing protocols, not by expert adjudication of its output, as it does not produce subjective or interpretative results like an AI diagnostic algorithm.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
Not performed/applicable. An MRMC study is relevant for AI systems that assist human readers in tasks like image interpretation to demonstrate improved diagnostic accuracy. This device is an "Injection Data Capture Device" providing feedback and recording information; it does not involve human readers interpreting data that the device enhances.
6. Standalone (Algorithm Only) Performance
While the device has software and algorithms to detect injection events and provide feedback, the document does not report "standalone" performance metrics in the way an AI diagnostic algorithm would (e.g., sensitivity, specificity). Its performance is demonstrated through the verification and validation of its hardware and software components (e.g., ability to detect spring position, successful data transfer, correct LED/audible feedback). The "Influence Testing" evaluates its performance in conjunction with the autoinjector, proving it does not negatively interfere.
7. Type of Ground Truth Used
The ground truth for the verification and validation of this device is engineering specifications, physical measurements, and adherence to established regulatory and industry standards. For example:
- Biocompatibility: Measured against established thresholds for cytotoxicity, sensitization, and irritation.
- EMC/Safety: Compliance with current versions of IEC standards.
- Software V&V: Compliance with software lifecycle processes and cybersecurity standards, and correct execution of defined functions (e.g., data recording, feedback activation).
- Mechanical/Lifetime: Physical measurements (e.g., activation force, dimension checks), cycle counts, and functional checks after simulated use/aging.
- Human Factors: User performance and subjective feedback against usability goals.
There is no "expert consensus," "pathology," or "outcomes data" ground truth in the context of its direct function (data capture and feedback).
8. Sample Size for the Training Set
Not applicable. This device is not an AI/machine learning system that requires a "training set" in the conventional sense (i.e., for learning to perform a complex, data-driven task like image recognition or diagnosis). Its functionality is based on programmed logic and sensor readings, not statistical learning from a large dataset.
9. How the Ground Truth for the Training Set Was Established
Not applicable, as there is no "training set" for the type of device described. Input signals (e.g., from the inductive sensor about spring position) are processed based on predefined engineering parameters and logical rules to determine injection status, not learned from a dataset.
Ask a specific question about this device
(268 days)
Tip (8881535762); Monoject™ 60mL Syringe, Luer-Lock Tip (8881560125)
Regulation Number: 21 CFR 880.5860
Monoject Syringes with Luer tip are intended for single use by health care professionals for general purpose fluid aspiration and and/or injection.
Not Found
The provided FDA 510(k) clearance letter pertains to Monoject™ Syringes, which are physical medical devices (piston syringes) and not an AI/ML software device. Therefore, the concepts of acceptance criteria for algorithm performance, study methodology for AI models, sample sizes for training/test sets, ground truth establishment, expert adjudication, or MRMC studies are not applicable to this document.
The letter indicates that the device has received substantial equivalence to legally marketed predicate devices, meaning it meets the safety and effectiveness requirements for its intended use, which is general purpose fluid aspiration and/or injection by healthcare professionals.
To answer your request, if this were an AI/ML device, the information would typically be found in the 510(k) submission summary or a separate clinical study report, neither of which is present in the provided FDA clearance letter. The letter itself is a notice of clearance, not a detailed technical report of the studies performed.
Therefore, I cannot extract the requested information from the provided document as it does not contain details about an AI/ML study or its performance criteria.
Ask a specific question about this device
(194 days)
Minnesota 55426
Re: K250127
Trade/Device Name: TSK Syringe
Regulation Number: 21 CFR 880.5860
Syringe
Classification Name: Low Dead Space Piston Syringe, Piston Syringe
Regulation Number: 880.5860
-|------------|
| Manufacturer | TSK Japan | Poonglim Pharmatech Inc. | N/A |
| Regulation | 21 CFR 880.5860
| 21 CFR 880.5860 | Same |
| Product Code | QNQ FMF | QNQ | Same |
| Class | II | II | Same |
| Regulation
The TSK Syringe is a low dead volume syringe intended for use in patients that need injection and withdrawal of substances for examination, treatment, diagnosis or prevention.
The TSK Syringe is a syringe intended for use with a needle to inject or withdraw substances, for general use. The TSK Syringe leaves a low volume of fluid when the plunger is fully depressed.
There are two model numbers for the TSK Syringe. The technological differences are as follows:
| Number | Syringe Nominal Capacity (mL) |
|---|---|
| TSY-0071P | 0.7 |
| TSY-0101Y | 1.0 |
The provided text is a 510(k) Clearance Letter and 510(k) Summary for the TSK Syringe. It details the device's characteristics, indications for use, and a comparison to a predicate device. However, it does not contain the specific information required to answer your request about acceptance criteria and a study proving device performance in the context of an AI/human reader study.
This document describes a physical medical device (syringe), not a software or AI-powered medical device that would involve AI performance metrics, human reader studies, ground truth establishment, or training/test set sample sizes in the way you've outlined.
Therefore, I cannot provide the requested information from this document. The details about acceptance criteria and study design for AI-based performance evaluation are not present.
Ask a specific question about this device
(90 days)
Jersey 07417
Re: K251350
Trade/Device Name: BD Plastipak™ Syringe
Regulation Number: 21 CFR 880.5860
Name: | BD Plastipak™ Syringe |
| Common Name: | Piston Syringe |
| Regulation Number: | 21 C.F.R. § 880.5860
510(k) Reference: | K980987 |
| Common Name: | Piston Syringe |
| Regulation Number: | 21 C.F.R. § 880.5860
The BD Plastipak™ Syringe is intended for use by health care professionals for general purpose fluid aspiration/injection.
The BD Plastipak™ Syringe is a three-piece, single use, sterile, hypodermic syringe with a 6% (Luer) male connector in 20 mL and 50 mL eccentric luer slip tip configurations. The BD Plastipak™ Syringe is intended for use by health care professionals for general purpose fluid aspiration/injection. The syringe assembly consists of a lubricated polypropylene barrel with a graduated scale, a lubricated synthetic rubber stopper and a polypropylene plunger rod. The plunger rod is pulled back to aspirate fluids or depressed to inject or expel fluids. The syringe barrel incorporates a male 6% (Luer) connector which is connectable to a compatible female 6% (Luer) connector. The BD Plastipak™ Syringe is provided sterile by Ethylene Oxide Gas (ETO) sterilization method.
The provided text is a 510(k) Clearance Letter for a medical device (BD Plastipak™ Syringe). It details the device's characteristics, intended use, and comparison to a predicate device. However, it does not describe an AI/ML-driven medical device or a study involving human readers or expert consensus for ground truth establishment.
The document discusses bench performance testing and biocompatibility tests for a physical device (syringe), not a software or AI-based diagnostic tool. Therefore, many of the requested criteria (like sample size for test/training set, number of experts, adjudication method, MRMC study, standalone performance, ground truth types) are not applicable to this specific submission.
Despite the irrelevance of some questions to the provided document, I will structure the answer based on the questions asked, indicating "Not Applicable" or providing the information that is present in the document.
Here's an analysis of the provided 510(k) clearance letter in the context of the requested information about acceptance criteria and study data:
This 510(k) clearance letter pertains to a physical medical device, the BD Plastipak™ Syringe, not an AI/ML-driven diagnostic or image analysis tool. As such, many of the typical acceptance criteria and study methodologies applicable to AI models (e.g., ground truth established by experts, MRMC studies, training/test set sizes for algorithms, human reader improvement with AI assistance) are not relevant or described in this document.
The "study" referenced in the document primarily consists of non-clinical performance and biocompatibility testing to demonstrate the substantial equivalence of the new syringe (with a changed barrel resin) to a previously cleared predicate syringe.
1. Table of Acceptance Criteria and Reported Device Performance
The document states, "The subject device met all the predetermined acceptance criteria for the above listed performance and biocompatibility tests." However, it does not explicitly list the quantitative acceptance criteria or the specific numerical performance results for each test. It only lists the tests performed and the standards they adhere to.
| Test Category | Test | Purpose (as described) | Acceptance Criteria (Not Explicitly Stated Quantitatively) | Reported Performance (Not Explicitly Stated Quantitatively) |
|---|---|---|---|---|
| Performance Testing | Breakout Force | ISO 7886-1:2017- Performance evaluation of force to operate the piston. | Met predetermined criteria (implied by "met all") | Subject device performed equivalent to predicate (implied) |
| Sustaining Force | ISO 7886-1:2017- Evaluation of force to operate the piston. | Met predetermined criteria (implied by "met all") | Subject device performed equivalent to predicate (implied) | |
| Leakage Past Stopper | ISO 7886-1:2017- Evaluation of Freedom from air and liquid leakage past plunger stopper. | Met predetermined criteria (implied by "met all") | Subject device performed equivalent to predicate (implied) | |
| Volumetric Accuracy | ISO 7886-1:2017- Evaluation of Volumetric Accuracy | Met predetermined criteria (implied by "met all") | Subject device performed equivalent to predicate (implied) | |
| Dead Space | ISO 7886-1:2017- Evaluation of residual volume | Met predetermined criteria (implied by "met all") | Subject device performed equivalent to predicate (implied) | |
| Luer Leakage | ISO 80369-7:2021 - Evaluation of the luer fittings for leakage | Met predetermined criteria (implied by "met all") | Subject device performed equivalent to predicate (implied) | |
| Stress Cracking | ISO 80369-7:2021- Evaluation of the luer fittings for stress cracking | Met predetermined criteria (implied by "met all") | Subject device performed equivalent to predicate (implied) | |
| Resistance to separation from axial load | ISO 80369-7:2021- Evaluation of the luer fitting for separation when subjected to axial force. | Met predetermined criteria (implied by "met all") | Subject device performed equivalent to predicate (implied) | |
| Biocompatibility Testing | Cytotoxicity | ISO 10993-5:2009- Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity | Met predetermined criteria (implied by "met all") | Subject device performed equivalent to predicate (implied) |
| Sensitization | ISO 10993-10:2021- Biological Evaluation of Medical Devices - Part 10: Tests for Skin Sensitization | Met predetermined criteria (implied by "met all") | Subject device performed equivalent to predicate (implied) | |
| Intracutaneous Reactivity | ISO 10993-23:2021- Biological evaluation of medical devices- Test for Irritation | Met predetermined criteria (implied by "met all") | Subject device performed equivalent to predicate (implied) | |
| Acute Systemic Toxicity | ISO 10993-11:2017- Biological evaluation of medical devices — Part 11: Tests for systemic toxicity | Met predetermined criteria (implied by "met all") | Subject device performed equivalent to predicate (implied) | |
| Material Mediated Pyrogenicity | ISO 10993-11:2017- Biological evaluation of medical devices — Part 11: Tests for systemic toxicity USP43-NF38 <151>Pyrogen Test (USP Rabbit Test) | Met predetermined criteria (implied by "met all") | Subject device performed equivalent to predicate (implied) | |
| Hemocompatibility | ISO 10993-4:2017- Biological evaluation of medical devices Part 4: Selection of tests for interactions with blood ASTM F756-17- Standard Practice for Hemolytic Properties of Materials | Met predetermined criteria (implied by "met all") | Subject device performed equivalent to predicate (implied) |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size for Test Set: Not specified in the provided document. The tests are "bench performance testing" on various syringe units.
- Data Provenance: Not specified, but generally, bench testing for physical devices is conducted in a controlled lab environment by the manufacturer. It is non-clinical.
- Retrospective or Prospective: Not applicable for this type of physical device testing.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
- Not Applicable. Ground truth for this physical device testing is established through standardized laboratory test methods and measurements against international or internal specifications, not by human experts interpreting clinical data.
4. Adjudication Method for the Test Set
- Not Applicable. (See point 3)
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- No. This is not an AI/ML device. Therefore, no MRMC study or assessment of human reader improvement with AI assistance was conducted or is relevant.
6. If a Standalone (i.e. algorithm only without human-in-the loop performance) was done
- No. This is not an AI/ML device. Therefore, no standalone algorithm performance was assessed. The performance tests are for the physical syringe itself.
7. The Type of Ground Truth Used
- The "ground truth" for this device's performance is based on measurements against established engineering specifications and international standards (e.g., ISO, ASTM, USP) for physical and material properties (e.g., force, leakage, volume accuracy, biocompatibility reactions). It is not based on expert consensus, pathology, or outcomes data in the clinical sense.
8. The Sample Size for the Training Set
- Not Applicable. This is not an AI/ML device. There is no concept of a "training set" in the context of the reported non-clinical bench testing for a physical syringe.
9. How the Ground Truth for the Training Set was Established
- Not Applicable. (See point 8)
Ask a specific question about this device
(25 days)
Profoject™ Disposable Syringe, Profoject™ Disposable Syringe with Needle
Regulation Number: 21 CFR 880.5860
Name: Piston syringe
Device Class: Class II
Product Code: FMF
Regulation Number: 21 CFR 880.5860
for single use with/without needle
Common Name: Piston Syringe
Regulation Number: 21 CFR 880.5860
withdraw fluid from body. | Same |
| Product code | FMF | FMF | Same |
| Regulation number | 21 CFR 880.5860
| 21 CFR 880.5860 | Same |
| Principle of operation | For manual use only | For manual use only |
The ProfojectTM Disposable Syringe and the ProfojectTM Disposable Syringe with Needle are intended to be used for medical purposes to inject fluid into or withdraw fluid from body.
The ProfojectTM Disposable Syringe is available in a sterile state. It is a single-use device comprising a polypropylene barrel with a Luer slip or Luer lock nozzle, a polypropylene plunger, and a polyisoprene rubber plunger stopper. Syringes are available in various volume specifications, ranging from 1mL to 60mL. The syringe barrel is printed with a legible graduated scale in milliliters. The syringe is compatible with U.S. legally marketed devices featuring Luer slip or Luer lock connectors that comply with ISO 80369-7. The syringe is intended for manual use only. The plunger of the syringe is pulled back to aspirate fluids or depressed to inject or expel fluids.
The ProfojectTM Disposable Syringe with Needle is supplied in a sterile state. It is a single-use device comprising a Luer slip or Luer lock syringe and a hypodermic needle. The hypodermic needle consists of a stainless steel needle tube, a polypropylene needle hub, and a polypropylene needle cap. The hypodermic needle is available in variety of combinations of needle gauge (18G, 20G, 21G, 22G, 23G, 25G, 26G, 27G) and needle length (15mm, 20mm, 25mm, 30mm, 38mm). Needle hubs are color-coded to identify the gauge of the needle tube. The Disposable Syringe with Needle is available in various combinations of syringe volume and needle size. It is intended for manual use only. The plunger of the syringe is pulled back to aspirate fluids or depressed to inject or expel fluids.
The provided FDA 510(k) clearance letter and summary for the Profoject™ Disposable Syringe and Profoject™ Disposable Syringe with Needle focuses on establishing substantial equivalence to a predicate device (K211211) through non-clinical testing. It does not describe a study involving an AI component, human readers, or a ground truth established in the way typical for AI/ML medical devices.
Therefore, the requested information regarding acceptance criteria, device performance, sample size for test sets, data provenance, expert ground truth establishment, adjudication methods, MRMC studies, standalone performance, and training set details are not applicable as this is a traditional medical device submission without an AI/ML component.
Instead, the submission relies on a comparison of technological characteristics and performance testing against recognized international standards for syringes and needles to demonstrate substantial equivalence.
Here's a summary based on the provided document, addressing the relevant points and noting where information is not applicable due to the nature of the device:
Acceptance Criteria and Study Details for Profoject™ Disposable Syringe
1. Table of Acceptance Criteria and Reported Device Performance
The acceptance criteria for this device are based on compliance with a comprehensive set of international standards rather than specific performance metrics directly stated in a table for each criterion. The "reported device performance" is indicated by the statement that the tests met the requirements of these standards.
| Acceptance Criterion (Compliance with Standard) | Reported Device Performance |
|---|---|
| Biocompatibility: | |
| ISO 10993-1:2018 (Cytotoxicity, Skin sensitization, Intracutaneous reactivity, Acute systemic toxicity, Pyrogen test, Hemocompatibility) | Met the requirements in the standards. |
| USP <788> Particulate Matter in Injections | Met the USP acceptance criteria. |
| Performance Testing: | |
| ISO 7886-1:2017 (Sterile hypodermic syringes for single use - Part 1: Syringes for manual use) | Complied with the standard. |
| ISO 7864:2016 (Sterile hypodermic needles for single use - Requirements and test methods) | Complied with the standard. |
| ISO 9626:2016 (Stainless steel needle tubing for the manufacture of medical devices - Requirements and test methods) | Complied with the standard. |
| ISO 80369-7:2021 (Small-bore connectors for liquids and gases in healthcare applications - Part 7: Connectors for intravascular or hypodermic applications) | Complied with the standard. |
| ISO 6009:2016 (Hypodermic needles for single use — Colour coding for identification) | Complied with the standard. |
| Sterilization, Package, and Shelf Life Testing: | |
| ISO 11135:2014 (Ethylene Oxide Sterilization Validation) | Validated, establishing routine control and monitoring parameters. |
| ISO 11737-1:2018+AMD1:2021 (Bioburden test) | Test results demonstrated compliance. |
| ISO 11737-2:2019 (Sterility test) | Test results demonstrated compliance. |
| ISO 10993-7:2008+AMD1:2019 (EO and ECH residue test) | Test results demonstrated compliance. |
| USP <85> (Bacterial Endotoxins Test) | Test results demonstrated compliance. |
| ISTA 3A:2018 (Simulated distribution testing for packaging) | Test results demonstrated compliance. |
| ASTM F88/F88M-23 (Seal strength) | Packaging found acceptable. |
| ASTM F1929-23 (Dye penetration) | Packaging found acceptable. |
| ASTM F1886/F1886M-16 (Visual inspection) | Packaging found acceptable. |
| ASTM F1140/F1140M-13 (Reapproved 2020)e1 (Internal pressurization) | Packaging found acceptable. |
| USP <71> (Sterility test for packaging) | Packaging found acceptable. |
| ASTM F1980-21 (Accelerated aging for shelf life) | Device shelf-life determined to be 5 years. |
| Labeling Compliance | Met the requirements of 21 CFR Part 801. |
2. Sample Size Used for the Test Set and Data Provenance
The document does not specify exact sample sizes for each test. It states that "the following tests have been performed" and that "the testing results demonstrate that the proposed device complies with the applicable standards requirements." For biocompatibility, performance, sterilization, package, and shelf-life testing, samples of the device were used as required by the specific standards.
- Sample Size: Not explicitly stated as a single number for a "test set." Samples were drawn and tested according to the requirements of each individual standard (e.g., ISO, ASTM, USP).
- Data Provenance: The tests were conducted by the manufacturer (CMT Health Pte. Ltd., based in Singapore) or their designated testing facilities to demonstrate compliance with international standards. This is prospective testing performed on manufactured devices.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications
N/A. This device is a traditional medical device (syringes) and not an AI/ML device requiring expert-established ground truth for a diagnostic test. The "ground truth" here is compliance with established engineering and biological safety standards.
4. Adjudication Method for the Test Set
N/A. Not applicable to engineering performance and biocompatibility testing of a physical device. Test results are compared directly against the quantitative or qualitative pass/fail criteria defined within the referenced international standards.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done
N/A. This is a traditional medical device (syringe), not an AI-assisted diagnostic or interpretative device. Therefore, MRMC studies are not relevant.
6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was done
N/A. This device does not involve an AI algorithm. Its performance is evaluated through bench testing against established standards.
7. The Type of Ground Truth Used
The "ground truth" for this device's acceptance is defined by the objective, measurable requirements and pass/fail criteria specified within the referenced international and national standards (ISO, ASTM, USP) for its physical, chemical, and biological properties. This includes:
- Engineering specifications (e.g., dimensions, force required for operation, leak integrity).
- Material safety (biocompatibility, leachable substances).
- Sterility assurance.
- Packaging integrity.
- Shelf-life stability.
8. The Sample Size for the Training Set
N/A. This is a traditional medical device and does not involve machine learning algorithms requiring a training set.
9. How the Ground Truth for the Training Set Was Established
N/A. No training set is applicable for this device.
Ask a specific question about this device
(114 days)
Turkey
Re: K250733
Trade/Device Name: 3DOSE 1ml Syringe
Regulation Number: 21 CFR 880.5860
Common Name: Piston syringe
Classification Name: Syringe, Piston
Regulation Number: 880.5860
Needle
510(k) Number: K191642
Classification Name: Syringe, Piston
Regulation Number: 880.5860
Classification | Class II | Class II | Same – both devices are classified as Class II. |
| Regulation Number | 880.5860
| 880.5860 | Same – both devices fall under regulation number 880.5860. |
| Indications for use | The
The 3DOSE 1ml Syringe is intended for use by health care professionals for general purpose fluid aspiration/ injection.
The 3DOSE 1ml Syringe is a sterile, single-use, disposable and non-reusable manual syringe which is intended for injection of fluids into the body. The syringe can be used for pulling up any mixture, and after operating the locking handle for accurate dosing according to the ml/unit scale on the plunger.
The 3DOSE 1ml Syringe is used like a classic syringe, but includes a feature that provides tactile and audible feedback to the user during dosing.
Models: 3DOSE 1ml Syringe (125 GREEN)
3DOSE 1ml Syringe (100 ORANGE)
The provided FDA 510(k) clearance letter for the 3DOSE 1ml Syringe does not detail any study involving human readers, AI, or diagnostic performance metrics typically associated with AI/ML-based medical devices. This clearance is for a piston syringe, a physical medical device, not an AI/ML software as a medical device (SaMD).
Therefore, I cannot provide information for the following points as they are not applicable to this device and its clearance documentation:
- A table of acceptance criteria and the reported device performance (in terms of diagnostic metrics like sensitivity, specificity, AUC)
- Sample sizes used for the test set and data provenance (for diagnostic performance of an algorithm)
- Number of experts used to establish the ground truth for the test set and their qualifications
- Adjudication method for the test set
- If a multi-reader multi-case (MRMC) comparative effectiveness study was done
- If a standalone (algorithm only) performance study was done
- The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
- The sample size for the training set
- How the ground truth for the training set was established
However, I can extract information related to the device's technical specifications, performance standards, and the non-clinical testing performed to establish its safety and effectiveness relative to a predicate device.
Here's the summary of acceptance criteria and the study that proves the device meets them, based on the provided document, specifically for a physical medical device (syringe):
1. Acceptance Criteria and Reported Device Performance (Non-Diagnostic)
For a physical device like a syringe, acceptance criteria relate to its physical properties, functionality, and compliance with recognized standards. The "performance" reported is its compliance with these standards, indicating mechanical functionality, material safety, and sterility.
| Category | Acceptance Criteria (Standard Compliance) | Reported Device Performance |
|---|---|---|
| Functional Performance | - ISO 7886-1:2017: Sterile Hypodermic syringes for single use - Part 1: Syringes for manual use - ISO 80369-7:2016: Small-bore connectors for liquids and gases in healthcare applications - Part 7: Connectors for intravascular or hypodermic applications - ISO 80369-20:2015: Small-bore connectors for liquids and gases in healthcare applications - Part 20: Common test methods | - Complies with ISO 7886-1:2017 - Complies with ISO 80369-7:2016 - Complies with ISO 80369-20:2015 (Demonstrated through "Functional Performance Testing") |
| Sterility | - ISO 11135: Sterilization of health-care products - Ethylene oxide - ISO 11607-1: Packaging for terminally sterilized medical devices - Part 1: Requirements for materials, sterile barrier systems and packaging systems - ISO 11607-2: Packaging for terminally sterilized medical devices - Part 2: Validation requirements for forming, sealing and assembly processes - ISO 10993-7: Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals | - Device is sterile, single-use, disposable. - Sterilized using Ethylene Oxide. - Validated shelf-life of 5 years. (Demonstrated through "Sterility" testing per listed ISO standards) |
| Biocompatibility | - ISO 10993-1: Biological Evaluation of Medical Devices - Part 1: Evaluation and Testing Within a Risk Management Process (including Cytotoxicity, Sensitization, Irritation, Acute Systemic Toxicity, Pyrogenicity, Hemocompatibility) - ISO 10993-4: Tests for interactions with blood - ISO 10993-5: Tests for in vitro cytotoxicity - ISO 10993-10: Tests for irritation and skin sensitization - ISO 10993-11: Tests for systemic toxicity - USP <788> Particulate Matter In Injections | - Biocompatibility evaluation conducted in accordance with ISO 10993-1 and FDA recognized standards. - Syringe of testing included Cytotoxicity, Sensitization, Irritation, Acute Systemic Toxicity, Pyrogenicity, Hemocompatibility. - All a-forementioned tests passed, demonstrating the device is biocompatible. (Demonstrated through "Biocompatibility Testing") |
| Chemical Properties | - ISO 7886-1 (Section for chemical properties: Limits for acidity or alkalinity, Limits for extractable metals) | - Chemical performances inspection based on ISO 7886-1. - Results conform to ISO 7886-1 for limits for acidity or alkalinity and extractable metals. (Demonstrated through "Chemical properties" testing) |
| Material/Design Integrity | - Functionality of the "audible/tactile feature" (ratcheting dose mechanism) - No negative effect on overall device performance due to new features (locking arm, plastic part, audible/tactile feedback) | - In-process quality control tests performed to confirm the audio notification mechanism works correctly and does not have a negative effect on overall performance. - Performance testing conducted for the ratcheting lock mechanism (locking arm, plastic part) to ensure it does not raise new questions of safety or effectiveness. (Demonstrated through implicit in-house testing/QC) |
2. Sample Sizes used for the Test Set and Data Provenance
The document does not specify exact sample sizes for each non-clinical test (e.g., how many syringes were tested for extractable metals or sterility). It generally states "The collective results of the nonclinical testing demonstrate..." This implies a sufficient number of samples were tested to meet the statistical requirements of the respective ISO standards.
- Data Provenance: The tests would have been performed in a laboratory setting, likely in Turkey (Bimed Teknik Aletler Sanayi & Ticaret A.S. is based in Istanbul, Turkey) or by accredited labs contracted by them. These are prospective tests performed specifically for this 510(k) submission.
3. Number of Experts used to establish the ground truth for the test set and the qualifications of those experts
This concept is not applicable here as there is no "ground truth" in the clinical diagnostic sense. The "truth" for device functionality, sterility, and biocompatibility is established by compliance with internationally recognized consensus standards (ISO, USP) and physical/chemical measurements by qualified laboratory personnel.
4. Adjudication method for the test set
Not applicable. This is not a study assessing human or AI diagnostic performance.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done
No. This type of study is for evaluating observer performance, typically in medical imaging or diagnostics, and is not relevant to a physical medical device like a syringe.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
No. This device is not an algorithm or software. It is a manually operated piston syringe.
7. The type of ground truth used
For this device, the "ground truth" is defined by the specifications and limits set by the referenced international standards (e.g., ISO 7886-1, ISO 10993 series). For example:
- Dimensional accuracy of volume: defined by ISO 7886-1 tolerances.
- Sterility: defined by ISO 11135 and ISO 11607 series (e.g., SAL of 10^-6).
- Biocompatibility: Defined by the absence of adverse biological reactions as per ISO 10993 series tests.
- Chemical properties: Defined by limits for acidity/alkalinity and extractable metals in ISO 7886-1.
8. The sample size for the training set
Not applicable. This is a physical device, not an AI/ML model that requires training data.
9. How the ground truth for the training set was established
Not applicable.
Ask a specific question about this device
(26 days)
Re: K251648**
Trade/Device Name: GPS Advanced and GPS Advanced Cannula
Regulation Number: 21 CFR 880.5860
Common/Usual Name:** Syringe, Piston
Device Classification: Class II
Regulation: 21 CFR §880.5860
GPS Advanced and GPS Advanced Cannula are intended for use to deliver FIBERGRAFT™ BG Putty GPS to a bone grafting site.
GPS Advanced is a sterile, single use dispenser for the delivery of FIBERGRAFT™ BG Putty GPS bone graft substitute. The dispenser has a ratcheted plunger that advances with each squeeze of its handle. The 5 cc GPS Advanced Cannula ("GPS Advanced Cannula") is available individually packaged and can be attached to the dispenser.
GPS Advanced is provided sterile via irradiation and GPS Advanced Cannula is provided sterile via ethylene oxide.
The GPS Advanced Cannula is provided empty and needs to be filled with FIBERGRAFT™ BG Putty GPS prior to use. FIBERGRAFT™ BG Putty GPS is a bioactive synthetic bone graft substitute in putty format made from 45S5 bioactive glass and has been previously cleared under K170306 (FIBERGRAFT™ BG Putty – Bone Graft Substitute) and K222276 (CONDUIT™ Cages and FIBERGRAFT™ BG Putty). FIBERGRAFT™ BG Putty GPS is not included in the GPS Advanced dispensing system.
Based on the provided FDA 510(k) clearance letter for "GPS Advanced and GPS Advanced Cannula," it's important to understand that this device is a piston syringe used for delivering a bone graft substitute. As such, the "acceptance criteria" and "study that proves the device meets acceptance criteria" are focused on the mechanical and functional performance of the syringe as a medical device, rather than the performance of an AI/ML algorithm or diagnostic tool.
Therefore, many of the typical questions asked about AI/ML device studies (like MRMC studies, standalone algorithm performance, AI training/test sets, ground truth establishment for AI) are not applicable to this type of device.
Here's a breakdown of the acceptance criteria and performance data as inferred from the document:
1. Table of Acceptance Criteria and Reported Device Performance
| Acceptance Criteria Category | Specific Criteria (Inferred) | Reported Device Performance (Inferred) |
|---|---|---|
| Biological Safety | Biocompatibility and safety of materials in contact with body fluids/tissue. | Met through Biological Risk Assessment. |
| Sterilization Efficacy | Device is sterile. | Met through Sterilization Validation (Irradiation for GPS Advanced, Ethylene Oxide for GPS Advanced Cannula). |
| Packaging Integrity | Packaging maintains sterility and protects device integrity over shelf-life. | Met through Packaging and Shelf-Life Testing. |
| Functional Performance | Device delivers the intended substance (FIBERGRAFT™ BG Putty GPS) effectively and reliably to the bone grafting site. | Met through functional evaluation (likely as part of Packaging and Shelf-Life Testing, and implicitly through similarity to predicate). The ratcheted plunger advances with each squeeze, allowing delivery. |
| Shelf-Life Stability | Device maintains its functional and sterile properties for its specified shelf-life. | Met through Shelf-Life Testing. |
| Design & Material Conformity | Design features, materials, and principle of operation are consistent with predicate devices and suitable for intended use. | "The technological characteristics, including design, materials, principle of operation and performance as well as intended use of GPS Advanced and GPS Advanced Cannula are consistent with those of the primary predicate and reference device." |
Explanation of Inferences:
- The document explicitly states that "The performance data for the subject devices consists of the following evaluations: Biological Risk Assessment, Sterilization Validation, Packaging and Shelf-Life Testing, including functional evaluation." These evaluations implicitly define the acceptance criteria for those aspects.
- The statement about "consistent with those of the primary predicate and reference device" implies that the new device must perform comparably to previously cleared devices in terms of its core technological characteristics and function.
2. Sample Size Used for the Test Set and Data Provenance
This information is not explicitly detailed in the provided 510(k) summary. For a mechanical device like a syringe, "sample size" typically refers to the number of units tested for various validations (e.g., how many syringes were subjected to sterilization, packaging, or functional tests). The document does not specify these numbers.
- Data Provenance: Not applicable in the context of clinical data for AI/ML. The "data" here refers to test results from various engineering and biological validations of the device itself.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of Those Experts
This concept is not applicable to this device. "Ground truth" in this context is established through engineering specifications, validated test methods (e.g., sterility testing, material biocompatibility standards), and direct functional testing, not by expert consensus on clinical images or interpretations.
4. Adjudication Method for the Test Set
This concept is not applicable to this device, as there's no "interpretation" or "diagnosis" being made that requires human adjudication. Device performance is determined by objective measurements and validation against established standards.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
No, an MRMC comparative effectiveness study was not done. This type of study is relevant for AI-assisted diagnostic devices where human readers (e.g., radiologists) interpret images with and without AI assistance. The GPS Advanced and GPS Advanced Cannula is a delivery device, not an AI diagnostic tool.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done
No, a standalone algorithm performance study was not done. This concept applies to AI/ML algorithms that perform a task independently (e.g., detecting a lesion on an image). The GPS Advanced and GPS Advanced Cannula is a physical medical device, not an algorithm.
7. The Type of Ground Truth Used
The "ground truth" for this device's performance is based on objective scientific and engineering standards and tests:
- Sterility Validation: Demonstration that the device meets established sterility assurance levels (e.g., SAL of 10^-6).
- Biocompatibility Standards: Compliance with ISO 10993 series for medical device biocompatibility.
- Functional Specifications: Ability to successfully deliver the specified volume of material, maintain pressure, resist leakage, and operate smoothly.
- Packaging Integrity Standards: Ability of the packaging to maintain sterility and physical integrity under specified conditions.
- Shelf-Life Parameters: Demonstration that the device retains its functional and sterile properties over its specified shelf-life.
8. The Sample Size for the Training Set
This concept is not applicable for this device. "Training set" refers to data used to train AI/ML algorithms. The GPS Advanced and GPS Advanced Cannula is a mechanical device, not an AI/ML system.
9. How the Ground Truth for the Training Set Was Established
This concept is not applicable for this device, as there is no "training set" in the AI/ML sense.
Ask a specific question about this device
Page 1 of 58